Profile
Douglas T.
Sheehy is Director at Aimmune Therapeutics UK Ltd. since 2017.
Mr. Sheehy will be Chief Legal Officer & Secretary at Mirum Pharmaceuticals, Inc. starting in 2025.
Formerly, Mr. Sheehy was Executive Director-Legal & Corporate Law at CV Therapeutics, Inc. from 2002 to 2007.
Mr. Sheehy was Secretary & Chief Legal Officer at Sonoma Biotherapeutics, Inc. from 2016 to 2020.
Mr. Sheehy served as Secretary, Chief Administrative Officer & EVP at Codexis, Inc. from 2014 to 2016.
Mr. Sheehy worked as Attorney at Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP from 1995 to 2000.
Mr. Sheehy was Attorney at Brobeck, Phleger & Harrison LLP from 1994 to 1995.
Mr. Sheehy was Secretary & General Counsel at Aimmune Therapeutics, Inc. from 2016 to 2020.
Mr. Sheehy earned a graduate degree from American University Washington College of Law in 1994 and an undergraduate degree from Dartmouth College in 1989.
Douglas Sheehy active positions
| Companies | Position | Start |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | General Counsel | 18/05/2025 |
Aimmune Therapeutics UK Ltd.
Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 30/03/2017 |
Former positions of Douglas Sheehy
| Companies | Position | End |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | General Counsel | 30/11/2020 |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | General Counsel | 31/12/2019 |
| CODEXIS, INC. | Chief Administrative Officer | 31/03/2016 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | General Counsel | 31/03/2007 |
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 31/07/2000 |
Training of Douglas Sheehy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Codexis, Inc.
Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Brobeck, Phleger & Harrison LLP
Brobeck, Phleger & Harrison LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
American University Washington College of Law
American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Aimmune Therapeutics UK Ltd.
Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
- Stock Market
- Insiders
- Douglas Sheehy
















